ARPA-E faces a tricky mandate—invest in risky technologies that no one else wants to fund, while still showing results.
The sell-off of synthetic biology pioneer LS9 goes to show that making biofuels from genetically engineered microbes has yet to deliver economically.
A new nerve interface gives a sense of touch to a prosthetic limb.
It may have finally found the missing piece it needs to move beyond relying solely on advertising.
Automation is reducing the need for people in many jobs. Are we facing a future of stagnant income and worsening inequality?
An enhanced geothermal project fractures hot rocks at unproductive wells, an approach with low financial risk.
Aquion manufactures cheap, long-lasting batteries for storing renewable energy.
A smarter credit card could mean new security features and other functionality.
The closure of two “ultra-private” e-mail services shows just how weak the system really is.